02:44:34 EST Fri 15 Nov 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Cannabis Summary for Oct. 16, 2019

2019-10-16 21:28 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The Canadian Securities Exchange Composite Index dropped 2.19 points to 450.17 Wednesday. Extractor Valens Groworks Corp. (VGW) earned $5.8-million in its fiscal third quarter of 2019 (ended Aug. 31, 2019), a dramatic improvement from the company's $10.5-million loss in fiscal Q2. The loss was as significant as it was because of one-time expenses that accounted for over $9-million, but the swing was substantial nonetheless. Valens saw a strong increase in its Q3 revenue, reaching $16.5-million, up from $8.8-million in Q2.

Part of Valens' turnaround was spurred by improvements in operational efficiency. The company had an impressive gross margin of 77 per cent in Q3, compared with a gross margin of 58 per cent in the quarter before. This compares well with fellow prominent cannabis extraction company, Medipharm Labs Corp. (LABS: $4.12). Medipharm had a gross margin of just 36 per cent for the second quarter ended June 30, 2019, and 31 per cent in the period before that. Although Medipharm is well behind Valens in terms of gross margin, it too recorded a profit in its most recent results. Medipharm also nearly doubled Valens' revenue with $31.4-million in Q2, compared with Valens' Q3 revenue of $16.5-million.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2019 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.